Document Detail


Optimization of the conditions for preservation of induced sputum: influence of freezing on cellular analysis.
MedLine Citation:
PMID:  16100195     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Induced sputum (IS) analysis is a noninvasive, valid, and reproducible method for evaluating airway inflammation. It has been suggested that freezing of IS samples in order to delay analysis is feasible. However, the optimal conditions for preservation of IS samples have not been determined. OBJECTIVES: To determine optimal freezing conditions of IS samples, ensuring adequate specimen quality for assessment of cell viability, total cell count, and differential cell count. SUBJECTS AND METHODS: Twenty-one subjects were enrolled: 6 healthy control subjects, 5 patients with allergic rhinitis, 5 patients with mild asthma, and 5 patients with severe asthma. Each came to the laboratory once for IS sampling. Cell plugs were homogenized with dithiothreitol and separated into 12 aliquots. Viability and total and differential cell counts were determined for each aliquot. Bovine serum albumin (BSA) with dimethylsulfoxide (DMSO) was added to half of the aliquots, and fetal bovine serum (FBS) with DMSO was added to the other half. One half of the aliquots containing BSA or FBS were frozen at -20 degrees C, and the other half were frozen at - 80 degrees C. After 3, 7, or 10 days, samples were thawed and total cell counts, viability, and differential cell counts were assessed. RESULTS: Slide quality and total cell counts did not vary significantly according to freezing duration, temperature, or medium when compared to nonfrozen control samples. With FBS at -80 degrees C, cell viability did not vary significantly between control samples and freezing for 3, 7, and 10 days (59% vs 54%, 59% vs 54%, and 58% vs 54%, respectively; p > 0.05), whereas every other condition showed a significant decrease. Freezing did not affect the eosinophil percentage significantly. CONCLUSION: Freezing of IS samples in FBS with DMSO at - 80 degrees C allows adequate preservation of IS specimens. Samples can be kept for at least 10 days in those conditions without significantly altering total cell counts, viability, and eosinophil percentage.
Authors:
Philippe Prince; Mylène Bertrand; Marie-Eve Boulay; Marie-Claude Bernier; Louis-Philippe Boulet
Related Documents :
23474115 - Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibitin...
16343475 - Water transport and iif parameters for a connective tissue equivalent.
16510845 - Freeze-thaw increases adeno-associated virus transduction of cells.
18544545 - Role of balloon occlusion for mononuclear bone marrow cell deposition after intracorona...
9870545 - Stereological studies of the effects of alpha-msh and camp on melanosomes in melanoma c...
22205045 - Comparison of in vitro and in vivo acute toxicity assays in etroplus suratensis (bloch,...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Chest     Volume:  128     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-15     Completed Date:  2005-09-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  980-5     Citation Subset:  AIM; IM    
Affiliation:
Unité de recherche en pneumologie, Centre de recherche de l'Hôpital Laval, Institut universitaire de cardiologie et de pneumologie de l'Université Laval, PQ, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Cryopreservation / standards*
Female
Humans
Male
Middle Aged
Sputum / cytology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors?: a questionnai...
Next Document:  Reaction patterns of the tracheobronchial wall to implanted noncovered metal stents.